z-logo
Premium
Wnt signalling in kidney diseases: dual roles in renal injury and repair
Author(s) -
Kawakami Takahisa,
Ren Shuyu,
Duffield Jeremy S
Publication year - 2013
Publication title -
the journal of pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.964
H-Index - 184
eISSN - 1096-9896
pISSN - 0022-3417
DOI - 10.1002/path.4121
Subject(s) - wnt signaling pathway , acute kidney injury , regeneration (biology) , kidney , biology , renal stem cell , microbiology and biotechnology , fibrosis , cancer research , medicine , signal transduction , pathology , stem cell , endocrinology , progenitor cell
Wnt signalling is a complex, highly conserved, cell‐to‐cell communication pathway in multicellular organisms, regulating cell fate, function and phenotype in development, and diseases, including neoplasia. Although the critical role of the Wnt pathway in nephrogenesis is well established, recent investigations have shown its involvement in many adult kidney diseases, including ischaemic kidney injury, glomerular diseases, diabetic nephropathy, interstitial fibrosis and cystic kidney diseases. Overall, activation of the Wnt pathway is deleterious to many chronic diseases of the kidney, contributing to the maintenance of cells in an activated state. In addition, the Wnt pathway is activated during repair and regeneration in animal models of acute ischaemic injury, a scenario that is frequently encountered in human acute kidney injury. This activation recapitulates features of nephrogenesis and appears to play an indispensable role in repair and regeneration in this acute setting. As tools are being developed to regulate the Wnt pathway intracellularly and at the cell surface, the Wnt pathway has become a potential avenue for urgently required novel therapeutics for treating human kidney diseases. In this review, we describe consensus models for major Wnt signalling cascades and then discuss their roles in kidney diseases.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here